China still has ‘catching up to do’ to become biotech powerhouse, JPMorgan says

A lag in foundational research and looming geopolitical risks will weigh on China’s bid to build a world-class biotechnology innovation ecosystem, even as the sector’s overseas momentum remains strong, according to JPMorgan. “In China, there is still some catching up to do in basic research…
This is a brief. The reporting belongs to South China Morning Post — read the complete story, with full context and credits, at the source.
Read the full story at South China Morning Post ↗scmp.com
More from the World desk
Just in

‘I didn’t notice his body being purple’: Byron Bay doula left newborn to inflate a jumping castle, court hears
Just in
Duckett makes ton, Renshaw takes wickets in ODI decider
Just in
Royal commission quizzes bikie on $165k bill for mystery work
Just in
